Literature DB >> 12946018

Acute encephalitis, a poliomyelitis-like syndrome and neurological sequelae in a hamster model for flavivirus infections.

Pieter Leyssen1, Romaric Croes, Philipp Rau, Sabine Heiland, Erik Verbeken, Raphael Sciot, Jan Paeshuyse, Nathalie Charlier, Erik De Clercq, Uta Meyding-Lamadé, Johan Neyts.   

Abstract

Infection of hamsters with the murine flavivirus Modoc results in (meningo)encephalitis, which is, during the acute phase, frequently associated with flaccid paralysis, as also observed in patients with West Nile virus encephalitis. Twenty percent of the hamsters that recover from the acute encephalitis develop life-long neurological sequelae, reminiscent of those observed, for example, in survivors of Japanese encephalitis. Magnetic resonance imaging and histology revealed severe lesions predominantly located in the olfactory-limbic system, both in hamsters with acute encephalitis as in survivors. Prominent pathology was also detected in the spinal cord of hamsters with paralysis. Modoc virus infections in hamsters provide a unique model for the study of encephalitis, a poliomyelitis-like syndrome and neurological sequelae following flavivirus infection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946018     DOI: 10.1111/j.1750-3639.2003.tb00028.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  12 in total

Review 1.  Neurological approaches for investigating West Nile virus disease and its treatment in rodents.

Authors:  John D Morrey; Venkatraman Siddharthan; Hong Wang
Journal:  Antiviral Res       Date:  2013-09-19       Impact factor: 5.970

2.  Pathogenesis of Modoc virus (Flaviviridae; Flavivirus) in persistently infected hamsters.

Authors:  A Paige Adams; Amelia P A Travassos da Rosa; Marcio R Nunes; Shu-Yuan Xiao; Robert B Tesh
Journal:  Am J Trop Med Hyg       Date:  2013-01-28       Impact factor: 2.345

3.  In vivo monitoring of acute flavivirus (Modoc) encephalitis with regional and whole-brain quantitative diffusion magnetic resonance imaging.

Authors:  Johann Sellner; Pieter Leyssen; Sabine Heiland; Philipp Rau; Johan Neyts; Francisco Martinez-Torres; Peter Schramm; Werner Hacke; Uta Meyding-Lamadé
Journal:  J Neurovirol       Date:  2004-08       Impact factor: 2.643

4.  The Viral Polymerase Inhibitor 7-Deaza-2'-C-Methyladenosine Is a Potent Inhibitor of In Vitro Zika Virus Replication and Delays Disease Progression in a Robust Mouse Infection Model.

Authors:  Joanna Zmurko; Rafael E Marques; Dominique Schols; Erik Verbeken; Suzanne J F Kaptein; Johan Neyts
Journal:  PLoS Negl Trop Dis       Date:  2016-05-10

5.  A rat model for hepatitis E virus.

Authors:  Yannick Debing; Niraj Mishra; Erik Verbeken; Kaat Ramaekers; Kai Dallmeier; Johan Neyts
Journal:  Dis Model Mech       Date:  2016-07-13       Impact factor: 5.758

6.  Astrocytes decrease adult neurogenesis during virus-induced memory dysfunction via IL-1.

Authors:  Charise Garber; Michael J Vasek; Lauren L Vollmer; Tony Sun; Xiaoping Jiang; Robyn S Klein
Journal:  Nat Immunol       Date:  2018-01-01       Impact factor: 25.606

Review 7.  A Review of Flaviviruses that Have No Known Arthropod Vector.

Authors:  Bradley J Blitvich; Andrew E Firth
Journal:  Viruses       Date:  2017-06-21       Impact factor: 5.048

8.  Exploratory re-encoding of yellow fever virus genome: new insights for the design of live-attenuated viruses.

Authors:  R Klitting; T Riziki; G Moureau; G Piorkowski; E A Gould; X de Lamballerie
Journal:  Virus Evol       Date:  2018-07-23

9.  Exchanging the yellow fever virus envelope proteins with Modoc virus prM and E proteins results in a chimeric virus that is neuroinvasive in SCID mice.

Authors:  Nathalie Charlier; Richard Molenkamp; Pieter Leyssen; Jan Paeshuyse; Christian Drosten; Marcus Panning; Erik De Clercq; Peter J Bredenbeek; Johan Neyts
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

Review 10.  Status presens of antiviral drugs and strategies: Part II: RNA VIRUSES (EXCEPT RETROVIRUSES).

Authors:  Erik De Clercq
Journal:  Adv Antivir Drug Des       Date:  2007-09-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.